HYBRID EVENT: You can participate in person at Orlando, Florida, USA or Virtually from your home or work.
Ebola Virus

Ebola virus, a member of the Filoviridae family, is responsible for severe and often fatal hemorrhagic fever in humans. First identified in 1976 during outbreaks in Sudan and the Democratic Republic of Congo, the virus has since caused sporadic but highly concerning outbreaks in Central and West Africa. Ebola virus is transmitted to humans from wildlife and spreads through human-to-human transmission via direct contact with the blood, secretions, organs, or other bodily fluids of infected individuals. Characterized by a high mortality rate, Ebola virus disease (EVD) manifests with symptoms such as fever, severe headaches, muscle pain, and, in advanced stages, internal and external bleeding. The virus has the potential to cause widespread outbreaks, posing significant public health challenges. Preventive measures include early identification, isolation of infected individuals, and the use of protective equipment. There is no specific antiviral treatment for Ebola, but supportive care and prompt medical intervention can improve outcomes. Ongoing research aims to develop vaccines and therapies to better combat this deadly virus and mitigate the impact of future outbreaks. International collaboration and surveillance efforts remain critical in managing and preventing the spread of Ebola virus.

Submit your abstract Today

Watsapp